SPC Financial Inc. Lowers Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPC Financial Inc. trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.4% in the third quarter, Holdings Channel.com reports. The institutional investor owned 6,511 shares of the exchange traded fund’s stock after selling 161 shares during the quarter. SPC Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $643,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. ORG Partners LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $40,000. ORG Wealth Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $44,000. Resources Management Corp CT ADV increased its stake in shares of SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after acquiring an additional 138 shares during the period. SOA Wealth Advisors LLC. raised its holdings in SPDR S&P Biotech ETF by 79.8% during the first quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock worth $57,000 after purchasing an additional 265 shares in the last quarter. Finally, Lynx Investment Advisory acquired a new stake in SPDR S&P Biotech ETF in the second quarter valued at about $58,000.

SPDR S&P Biotech ETF Trading Down 0.9 %

NYSEARCA XBI opened at $99.30 on Friday. The stock has a market capitalization of $7.57 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business’s 50 day moving average is $99.00 and its two-hundred day moving average is $94.31. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.